News

In a landmark study of 125 Australian children with high-risk cancer, researchers have found that they can improve the chances of finding the right drug to kill their individual cancer through a new system of rapid drug screening.

According to a study, cancer research centers conducting clinical trials could enroll more patients from underrepresented racial and ethnic groups by placing greater emphasis on relieving investigators of the costs of translating consent documents.

In a study, vulnerable people at risk of severe COVID-19 achieved good antibody levels after three doses of mRNA vaccine.

Targeting the membrane of a virus, rather than its proteins, could lead to a new generation of antivirals.

A world-first human trial has revealed that inoculation with live hookworms resulted in modest improvements in insulin resistance in a small study of 40 participants at risk for type 2 diabetes.

Researchers have developed a novel metric for an underserved research area to aid healthcare providers in advising on maternal medication use for breastfeeding mothers or nursing persons.

Genomic sequencing had a huge impact in the global response to COVID-19, and the technology improved as more researchers put it to use.

PARP inhibitor drugs are currently used to treat some breast, ovarian and prostate cancers. New research suggests these drugs could also be used to treat cancers with changes to the SF3B1 gene.

Researchers have used mass spectrometry to identify ten blood proteins associated with mortality in severe burns. Three of these proteins may serve as targets for developing new treatment methods for burns.

CAR-T immune therapies could be effective against solid tumors if the right targets are identified, a new study led by University of Illinois Urbana-Champaign researchers suggests.